Finance

Lists
Z1BH34:BVMF
Zimmer Biomet Holdings Inc Bdr
R$121.92
0.00%
(0.00) 1D
Aug 4, 2:46:06 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for Z1BH34...
Mkt. cap
18.92B
Avg. vol.
19.00
Volume
0.00
52-wk high
R$126.34
52-wk low
R$111.45
Shares outstanding
190.74M
No. of employees
17K
Mkt. cap
18.92B
Avg. vol.
19.00
Volume
0.00
52-wk high
R$126.34
52-wk low
R$111.45
Shares outstanding
190.74M
No. of employees
17K
News stories
From web sources and news partners
Profile
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
About Zimmer Biomet Holdings Inc Bdr
CEOIvan Tornos
Employees17K
Founded1927
HeadquartersWarsaw, Indiana, United States
SectorMedical device
Websitezimmerbiomet.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.00B
2.24B
2.09B
2.18B
Cost of goods sold
559.30M
795.50M
564.20M
635.50M
Cost of revenue
559.30M
795.50M
564.20M
635.50M
Research and development expenses
115.90M
118.70M
103.40M
104.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
809.40M
838.50M
846.20M
882.30M
Operating expense
1.10B
1.13B
1.11B
1.15B
Total operating expenses
1.66B
1.93B
1.68B
1.79B
Operating income
340.30M
313.40M
410.80M
391.00M
Other non operating income
6.20M
15.10M
5.50M
6.00M
EBT including unusual items
279.20M
97.90M
301.30M
255.10M
EBT excluding unusual items
269.30M
250.00M
340.20M
320.80M
Income tax expense
48.00M
-39.90M
63.00M
55.50M
Effective tax rate
17.19%
-40.76%
20.91%
21.76%
Other operating expenses
-
-
-
-
Net income
230.90M
139.30M
238.10M
198.30M
Net profit margin
11.54%
6.21%
11.41%
9.11%
Earnings per share
1.90
2.42
2.09
2.07
Interest and investment income
-
-
-
-
Interest expense
-75.40M
-71.90M
-68.80M
-72.90M
Net interest expenses
-75.40M
-71.90M
-68.80M
-72.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
623.90M
597.40M
680.80M
661.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps